Home

Press Releases

12345678910
Tharimmune Advances TH104 for Prophylaxis Against Weaponized Fentanyl and Other High-Potency Opioids Following Positive FDA Feedback
BRIDGEWATER, NEW JERSEY / ACCESS Newswire / April 28, 2025 / Tharimmune, Inc., (Nasdaq:THAR) ("Tharimmune" or the "Company") a clinical-stage biopharmaceutical company focused on developing innovative therapeutics in inflammation & immunology, recently announced positive feedback from the U.S. Food and Drug Administration (FDA) regarding TH104. The agency confirmed that no additional clinical trials appear to be necessary prior to a 505(b)(2) New Drug Application (NDA) submission. TH104 is a buccal film formulation, of nalmefene specifically designed for rapid absorption with a potential for bypassing liver metabolism. This allows TH104 to be suitable for the temporary prophylaxis of respiratory and/or nervous system depression in military personnel and chemical incident responders who may be exposed to high-potency opioids, including weaponized fentanyl and its analogues.
Via ACCESS Newswire · April 28, 2025
Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval
BERKELEY, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, today reviewed its major accomplishments of the first quarter of 2025, and provided an outlook on its path to FDA premarket approval.  
By Mainz BioMed NV · Via GlobeNewswire · April 28, 2025
Rigetti Granted Air Force Office of Scientific Research Award to Further Develop Breakthrough Chip Fabrication Technology
The $5.48 million Rigetti-led consortium will include Iowa State University, the Royal Melbourne Institute of Technology, the University of Connecticut, and Lawrence Livermore National Laboratory. The project aims to develop a deeper understanding of how Rigetti’s novel chip fabrication process, Alternating-Bias Assisted Annealing (ABAA), reduces defects in superconducting qubits.
By Rigetti Computing, Inc. · Via GlobeNewswire · April 28, 2025
Smart Share Global Limited Files Its Annual Report on Form 20-F
SHANGHAI, April 28, 2025 (GLOBE NEWSWIRE) -- Smart Share Global Limited (Nasdaq: EM) (“Energy Monster” or the “Company”), a consumer tech company providing mobile device charging service, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the United States Securities and Exchange Commission (the “SEC”) on April 28, 2025. The annual report can be accessed on the Company’s investor relations website at https://ir.enmonster.com/ and on the SEC’s website at www.sec.gov.
By Smart Share Global Limited · Via GlobeNewswire · April 28, 2025
Family Private Care Champions Senior Home Care in Sandy Springs, GA
Sandy Springs, GA - Family Private Care is proud to announce its continued commitment to enhancing the quality of life for seniors through compassionate, tailored senior home care services. As a trusted name in Sandy Springs, GA, senior home care, the organization addresses the growing demand for high-quality, personalized in-home care, ensuring seniors can age comfortably and safely in familiar surroundings.
Via Get News · April 28, 2025
WEX Launches WEX EV Depot for Secure On-Site Vehicle Charging Payments
WEX (NYSE: WEX), the global commerce platform that simplifies the business of running a business, today announced the introduction of WEX EV Depot. This new feature enables simple, secure, and frictionless charging at private chargers when using the WEX Fleet Card. The newest addition to WEX’s comprehensive charging platform - including the existing public charging 'En Route’ and ‘At-Home’ solutions - makes it the first fleet management business in North America to offer electric vehicle (EV) charging payments across depot, public, and at-home charging locations.
By WEX · Via Business Wire · April 28, 2025
Mitek Appoints Industry Expert Garrett Gafke as Chief Operating Officer to Accelerate Growth and Innovation
Mitek Systems, Inc. (NASDAQ: MITK), a global leader in digital identity verification, fraud prevention, and biometrics, today announced the appointment of Garrett Gafke as Chief Operating Officer. A recognized entrepreneur and Fortune 500 executive, Mr. Gafke brings decades of experience scaling and transforming technology businesses across risk, fraud, and digital identity.
By Mitek Systems, Inc. · Via Business Wire · April 28, 2025
Smartlinx Acquires Software Provider StafferLink to Streamline Workforce Operations in Healthcare
Smartlinx, a leading provider of workforce management solutions for senior care organizations, has acquired StafferLink, a provider of contingent staffing management software for the healthcare industry.
By Lone View Capital · Via Business Wire · April 28, 2025
CrowdStrike Delivers Industry-First Managed Threat Hunting Across Third-Party Data
RSA 2025 - CrowdStrike (NASDAQ: CRWD) today introduced Falcon® Adversary OverWatch Next-Gen SIEM, the first and only solution to bring managed threat hunting to third-party data. This breakthrough innovation extends the visibility of CrowdStrike’s elite threat hunters into unmanaged attack surfaces adversaries have long exploited. By leveraging third-party data ingested by Falcon® Next-Gen SIEM, CrowdStrike delivers 24/7 expert detection beyond endpoints, identity and cloud environments to stop breaches across every attack surface.
By CrowdStrike · Via Business Wire · April 28, 2025
Phaseshift Technologies Appoints Mark Comerford to Board of Directors
Phaseshift Technologies (“Phaseshift”), an advanced materials company specializing in the development and commercialization of next-generation alloys and composites through its proprietary AI-powered computational platform, Rapid Alloy Design (RAD)™, announced the appointment of Mark Comerford to its Board of Directors.
By Phaseshift Technologies · Via Business Wire · April 28, 2025
HistoSonics’ Histotripsy System Demonstrates 90% Local Tumor Control at 12 Months in #HOPE4LIVER Trials
HistoSonics, the developer of the Edison Histotripsy System, announced today 12-month follow-up clinical data from its prospective #HOPE4LIVER trials, designed to evaluate the safety and efficacy of histotripsy for the non-invasive destruction of primary (hepatocellular cancer-HCC) and metastatic liver tumors.
By HistoSonics · Via Business Wire · April 28, 2025
Wells Fargo Confirms Termination of 2018 CFPB Compliance Consent Order
Wells Fargo & Company (NYSE: WFC) today confirmed that the Consumer Financial Protection Bureau’s (CFPB) 2018 consent order related to the company’s compliance risk management program has terminated. This is the twelfth consent order closed by Wells Fargo’s regulators since 2019 and the sixth since the beginning of the year.
By Wells Fargo & Company · Via Business Wire · April 28, 2025
AST SpaceMobile and U.S. National Science Foundation Establish Coordination Agreement Between Satellite and Ground-Based Astronomy Operations
AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by everyday smartphones, designed for both commercial and government applications, today announced it has signed a Coordination Agreement with the U.S. National Science Foundation (NSF) to implement best practices between satellite communications and ground-based optical, infrared, and radio astronomy observations.
By AST SpaceMobile, Inc. · Via Business Wire · April 28, 2025
DTN Launches First Hurricane Forecasting Tool That Captures Full Range of Threats
DTN, a global leader in data, analytics, and technology solutions serving agriculture, energy, and weather-sensitive industries, today announced the launch of the Hurricane Threat Index. It is the first forecasting tool to expand risk assessment and communication beyond traditional wind speed to include wind damage, storm surge, extreme rainfall, flooding and tornadic activity. The multi-factor index enables companies and communities within the radius of impact to make more confident preparedness and response decisions up to seven days before landfall.
By DTN · Via Business Wire · April 28, 2025
Media Advisory: Surescripts Experts to Present Innovative Interoperability & Prior Authorization Technologies at 2025 NCPDP Annual Conference May 5-7
Surescripts®, the nation's leading health intelligence network, will host presentations featuring innovative technologies and advances in health intelligence sharing that support providers to improve patient care experiences during the 2025 NCPDP Annual Conference, May 5-7, in Scottsdale, AZ.
By Surescripts · Via Business Wire · April 28, 2025
Diversified Healthcare Trust Closes $109 Million 10-Year Fixed-Rate Mortgage Financing Secured by Seven SHOP Communities
Diversified Healthcare Trust (Nasdaq: DHC) today announced that it closed a $109 million 10-year fixed rate mortgage financing through Freddie Mac. The loan is secured by seven senior living communities consisting of 1,184 units located in five states that are managed by Five Star Senior Living, the operating division of AlerisLife Inc. The loan has a 6.22% fixed interest rate, with interest only payable during the first 5 years and matures on May 1, 2035. DHC intends to use the loan proceeds to redeem a portion of its outstanding 9.750% senior notes due 2025.
By Diversified Healthcare Trust · Via Business Wire · April 28, 2025
VitriVax Receives Grant From the Coalition for Epidemic Preparedness Innovations (CEPI) to Leverage ALTA® Technology for Single-Dose Rabies Vaccine
VitriVax, Inc., a formulation technology company, announced a new grant of up to $5M from the Coalition for Epidemic Preparedness Innovations (CEPI). The grant will enable VitriVax to develop the Atomic Layering Thermostable Antigen and Adjuvant (ALTA®) technology further using Rabies as a vaccine target. ALTA® could replace multi-dose vaccines for protection against infectious diseases with a single-administration alternative. The company’s innovative approach in the pharma industry, known as ‘atomic layering deposition’, is used to control the release of the vaccine in the body over time.
By VitriVax, Inc. · Via Business Wire · April 28, 2025
Kairos Pharma, Ltd. Announces Data to be Presented at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical stage biopharmaceutical company, announces it will be presenting at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting to be held May 30-June 3, 2025 at McCormick Place, Chicago, Ill.
By Kairos Pharma, Ltd · Via Business Wire · April 28, 2025
Operation HOPE and Financial Literacy for All’s Green Socks Day Takes Place This Week on April 30
With just days to go until Green Socks Day on April 30, excitement is building across the country as a growing list of major corporations and leading organizations join individuals as they step up to support this national call to action for financial literacy.
By Operation HOPE · Via Business Wire · April 28, 2025
MWG Holdings Sweeps Multiple Categories in 2025 NuggMD Patient Choice Awards
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · April 28, 2025
Alnylam Receives Positive CHMP Opinion for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNA interference (RNAi) therapeutics company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of its RNAi therapeutic vutrisiran for the treatment of wild type or hereditary transthyretin amyloidosis in adult patients with cardiomyopathy (ATTR-CM). ATTR-CM is a debilitating, rapidly progressive and potentially fatal disease for which there are limited treatment options. Vutrisiran is currently approved in the European Union (EU) under the brand name AMVUTTRA® for the treatment of hereditary transthyretin-mediated (hATTR) amyloidosis in adult patients with stage 1 or stage 2 polyneuropathy.
By Alnylam Pharmaceuticals, Inc. · Via Business Wire · April 28, 2025
Berkshire Hathaway Specialty Insurance Makes Two Customer & Broker Engagement Appointments in the U.S.
Berkshire Hathaway Specialty Insurance (BHSI) today announced that it has named Gabe Poppie as Strategic Growth Broker Leader and named Brian Cummins as Customer & Broker Engagement Leader for the U.S. Northern Central region.
Newegg Announces Fiscal Year 2024 Results
Newegg Commerce, Inc. (NASDAQ: NEGG), a leading global technology e-commerce retailer, today announced results for the fiscal year ended December 31, 2024.
By Newegg Commerce Inc. · Via Business Wire · April 28, 2025
Boston Pharmaceuticals to Present the Effect of Efimosfermin Alfa on Collagen Biomarkers in Patients with F2 and F3 MASH at EASL Congress 2025
Boston Pharmaceuticals, a clinical-stage biopharmaceutical company developing efimosfermin alfa, a once-monthly FGF21 analogue for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), today announced it will present results from an analysis of its Phase 2 study in participants with stage F2 and F3 fibrosis due to MASH. The findings will be presented at the European Association for the Study of the Liver (EASL) Congress 2025, May 7-10, in Amsterdam.
By Boston Pharmaceuticals · Via Business Wire · April 28, 2025
New Cloud Security Alliance Certification Program Equips Professionals With Skills to Ensure Responsible and Safe Development and Management of Artificial Intelligence (AI)
The Cloud Security Alliance (CSA), the world’s leading organization dedicated to defining standards, certifications, and best practices to help ensure a secure cloud computing environment, has partnered with Northeastern University to develop the Trusted AI Safety Knowledge & Certification Program. This program is designed to equip professionals with the necessary skills and knowledge to ensure the safe, secure, and responsible development, deployment, and management of Artificial Intelligence (AI) systems.
By Cloud Security Alliance · Via Business Wire · April 28, 2025
ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI
SOLANA BEACH, CA / ACCESS Newswire / April 28, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, announces that today its partner, Clinical Laserthermia Systems AB (publ) (CLS), completed the submission of its 510(k) application to the FDA, expanding the indication of the ClearPoint Prism Neuro Laser Therapy System to include 1.5 T MRI guidance.
Via ACCESS Newswire · April 28, 2025
Newsmax Signs Deals in Israel and Armenia
Latest Agreements Continue Network's Rapid Global Growth in Over 100 Countries Across Five Continents
Via ACCESS Newswire · April 28, 2025
Owe Back Taxes and Not Sure What to Do? Clear Start Tax Highlights Common Mistakes and How to Avoid Them
Clear Start Tax Shares What Not to Do When You're Behind With the IRS—and the Smartest Ways to Start Resolving Your Debt
Via ACCESS Newswire · April 28, 2025
Afinida CEO Norman Tipton Retires, Search for Replacement Underway
Company thanks the outgoing CEO for his many years of oversight that has accelerated growth in Afinida and Trucept companies.
Via ACCESS Newswire · April 28, 2025
Living Security's Unify Platform Just Got Smarter-3X More Visibility, Zero Blind Spots, and AI-Powered Adaptive Intelligence That Connects Your Siloed Security Data
AUSTIN, TX / ACCESS Newswire / April 28, 2025 / Living Security, the global leader in human risk defense, today unveils powerful adaptive intelligence capabilities within its Unify platform. By fusing human expertise from its Human Intelligence Team (HInT), advanced AI phishing simulations, and industry-wide threat telemetry, Unify now delivers a minimum of 3X more visibility into human risk compared to outdated security awareness tools. This advancement is validated by third-party research from Cyentia.
Via ACCESS Newswire · April 28, 2025
Dalia Pearson Joins Sterling Organization as Chief Financial Officer
Dalia holds a Master of Accounting and a Bachelor of Science in Accounting, earned with magna cum laude honors, from Florida Atlantic University, completed the High Potentials Leadership Program at Harvard Business School and is a licensed Certified Public Accountant in the State of Florida.
Via ACCESS Newswire · April 28, 2025
Progressive Supranuclear Palsy Phase 2 Platform Clinical Trial Announces the Selection of AADvac1 and AZP2006 for its First Two Regimens
LONDON, GB / ACCESS Newswire / April 28, 2025 / The Progressive Supranuclear Palsy (PSP) Trial Platform (PTP), led by Drs. Adam Boxer (University of California, San Francisco [UCSF]), Irene Litvan (University of California, San Diego), Julio Rojas (UCSF) and Anne-Marie Wills (Massachusetts General Hospital), has selected two promising drug candidates-Axon Neuroscience's AADvac1 and Alzprotect's AZP2006-for inclusion in the platform trial as the first two compounds to be evaluated. The trial aims to accelerate the development of effective treatments for PSP, a rare and fatal neurodegenerative disease. Additional compounds to be evaluated in the trial are expected to be announced later this year.
Via ACCESS Newswire · April 28, 2025
AEye Sends Letter to Stockholders Regarding the 2025 Annual Meeting
AEye, Inc. (Nasdaq: LIDR), a global leader in adaptive, high-performance lidar solutions, sent a letter to stockholders today highlighting key information to support informed voting at its upcoming annual meeting on May 15, 2025. Stockholders of record as of April 4, 2025 are entitled to vote at this year’s meeting.
By AEye, Inc. · Via Business Wire · April 28, 2025
Financial Services Firms Deepen Client Engagement with ON24-powered Digital Experiences
ON24 (NYSE: ONTF), a leading intelligent engagement platform for B2B sales and marketing, today released its 2025 Financial Services Digital Engagement Benchmarks Report, highlighting how financial services and asset management firms are transforming client education through digital engagement. The findings show a surge in interactive, data-driven experiences, with firms leveraging first-party engagement from webinars, virtual events, and content hubs to foster deeper relationships, enhance awareness and drive pipeline growth.
By ON24 · Via Business Wire · April 28, 2025
Qdrant Receives Industry Honors for Innovation in AI and Vector Search
Qdrant, the high-performance, open-source vector database, today announced that it received two esteemed industry accolades. CB Insights named Qdrant to its ninth annual AI 100 list, honoring the 100 most promising private artificial intelligence companies globally. In addition, Qdrant won a 2025 AI TechAward in the "Data Storage and Access" category, to be presented at the upcoming AI DevSummit 2025 in San Francisco, CA.
By Qdrant · Via Business Wire · April 28, 2025
Sensydia Announces First Patient Enrolled in Pivotal Study of Non-Invasive Cardiac Performance System (CPS™)
Sensydia, a medical technology company pioneering non-invasive cardiac assessment, today announced that the first patient has been enrolled in its multi-center pivotal study to evaluate the accuracy of the Cardiac Performance System (CPS) for hemodynamic assessment as compared to the gold-standard: invasive right heart catheterization.
By Sensydia · Via Business Wire · April 28, 2025
SS&C Announces 2025 SS&C Deliver EMEA Conference
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced the return of its flagship EMEA event, SS&C Deliver, taking place May 13-14, 2025, at the Fairmont Windsor Park, just outside London. With the theme “Delivering the Future,” the exclusive, invitation-only conference will convene over 200 senior leaders from across financial services to explore the technologies, strategies, and insights shaping the future of global investment management.
By SS&C · Via Business Wire · April 28, 2025
MWG Holdings Sweeps Multiple Categories in 2025 NuggMD Patient Choice Awards
Perfect Union Northside Dispensary Earns Top Honors for Customer Experience; 5G Pop Recognized as Best Cannabis Beverage
Via TheNewswire.com · April 28, 2025
Space Flight Laboratory (SFL) Announces Key Milestone in Development of Aspera Space Astronomy Microsatellite Mission
Space Flight Laboratory (SFL) has completed assembly of the Aspera space astrophysics microsatellite bus. The spacecraft is ready for integration with the far-UV Aspera telescope being built by the University of Arizona. SFL will perform instrument-spacecraft integration and testing at its Toronto facility later this year with launch slated for early 2026.
By Space Flight Laboratory · Via Business Wire · April 28, 2025
IFF Expands Pet Portfolio with Latest Science-driven Solutions
IFF (NYSE: IFF), a global powerhouse in bioscience and innovation, today announced a groundbreaking expansion of its pet portfolio. This launch marks a significant leap in IFF’s mission to revolutionize companion animal care through advanced biotechnology and innovation.
JLens and ADL Urge Meta Shareholders to Vote FOR Shareholder Proposal Addressing the Risks of Online Antisemitism and Other Forms of Hate
JLens, a Registered Investment Advisor, and the Anti-Defamation League (ADL) today jointly called on shareholders of Meta Platforms, Inc. (NASDAQ: META) (“Meta” or the “Company”) to support Shareholder Proposal 8, which appears in the proxy for the Company’s annual meeting of shareholders, scheduled to be held on May 28, 2025.
By JLens · Via Business Wire · April 28, 2025
Fuzzy’s Taco Shop to Open First California Location in Barstow
Fuzzy’s Taco Shop, the fast-casual+ restaurant brand known for serving up good vibes, is making its highly anticipated debut in California with a new location in Barstow, opening today, April 28, 2025. Located at 1523 East Main Street, Barstow, CA 92311, this marks the brand’s first foray into the California market, bringing its signature tacos, memorable drinks, and laid-back vibe to the West Coast.
By Fuzzy’s Taco Shop · Via Business Wire · April 28, 2025
Affiliated Workers Association Addresses Small Business Health Care Concerns with New Partnership
Frisco, Texas--(Newsfile Corp. - April 28, 2025) - Affiliated Workers Association (AWA), a leading not-for-profit organization dedicated to supporting entrepreneurs...
Via Newsfile · April 28, 2025
Nocion Therapeutics Appoints Matthew Frankel, M.D., MBA to Chief Medical Officer
Nocion Therapeutics, Inc., a clinical stage biopharmaceutical company developing novel small molecule charged sodium channel blockers called “nocions”, that selectively affect actively firing nociceptors for the treatment of serious conditions involving cough, itch, and pain, today announced that it had appointed Matthew Frankel, M.D., MBA as Chief Medical Officer.
By Nocion Therapeutics, Inc. · Via Business Wire · April 28, 2025
Schrödinger Presents New Preclinical Data at AACR Annual Meeting
Schrödinger, Inc. (Nasdaq: SDGR) presented preclinical data on SGR-3515, its investigational Wee1/Myt1 co-inhibitor today at the American Association for Cancer Research (AACR) Annual Meeting 2025. The data demonstrated that SGR-3515 has improved anti-tumor activity in preclinical models compared to known Wee1 and Myt1 monotherapy inhibitors. The poster also described how the dosing schedule of SGR-3515 can be optimized to preserve efficacy and minimize target-related side effects. New data was also presented on the development of a computational method that predicts the response to Wee1-based drug combinations, including in novel cancer settings such as head and neck cancers. Schrödinger expects to report initial data from the ongoing Phase 1 clinical trial of SGR-3515 in patients with advanced solid tumors in the second half of 2025.
By Schrödinger · Via Business Wire · April 28, 2025
Easterly Government Properties Completes Reverse Stock Split
Easterly Government Properties, Inc. (NYSE: DEA) (the “Company” or “Easterly”), a fully integrated real estate investment trust focused primarily on the acquisition, development and management of Class A commercial properties leased to U.S. Government agencies, today announced that it completed its previously announced reverse stock split of the Company’s common stock (the “Common Stock”) at a ratio of 1-for-2.5 (the “Reverse Stock Split”).
enGene to Participate in Upcoming Investor Conferences
enGene Holdings Inc. (Nasdaq: ENGN or “enGene” or the “Company”), a clinical-stage, non-viral genetic medicines company, today announced that management will present at upcoming investor conferences in May 2025. Details of the conferences are below:
By enGene Holdings Inc. · Via Business Wire · April 28, 2025
Dollar Tree Announces Chief Supply Chain Officer Transition
Dollar Tree, Inc. (NASDAQ: DLTR) today announced that Chief Supply Chain Officer Mike Kindy will retire, and that Roxanne Weng has been appointed as the company’s new Chief Supply Chain Officer.
By Dollar Tree, Inc. · Via Business Wire · April 28, 2025
New Research Finds Building with Zinc Prevents Substantial Carbon Emissions
Using zinc to build a single home prevents more than 50 tonnes in carbon emissions, and if just ten percent of new homes in North America were built using zinc, more than 40 million tonnes in carbon emissions would be prevented. These impressive numbers demonstrating zinc’s success story as an agent of decarbonization are the first results of the International Zinc Association’s new Zinc Enables Decarbonization (ZED) initiative, a partnership between the International Zinc Association and Environmental Economist Benjamin Cox, Program Director of the Bradshaw Research Institute for Minerals and Mining at the University of British Columbia.
By International Zinc Association · Via Business Wire · April 28, 2025
PetPace™ Wins Global Tech Award for Wearable Technology, Marking Third Major Industry Honor
PetPace™, the leader in AI-powered wearable pet health technology, is proud to announce that it is a Global Tech Award winner in the Wearable Technology category. This marks the company’s third major accolade, adding to its growing list of award-winning pet health solutions, including the IoT Breakthrough Award for IoT Wearable Device of the Year and the PCMag Excellence Award for their smart pet care platform.
By PetPace · Via Business Wire · April 28, 2025